Biological E's Corbevax has been approved as a booster dose for adults, & those who are fully vaccinated with Covishield or Covaxin. This is for the 1st time that a booster dose that is different from the one used for primary vaccination has been allowed in India.

The Union Health Ministry's approval is based on the recommendations made recently by the COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI).

  

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

WHAT?

Biological E's Corbevax has been approved as a booster dose for adults, & those who are fully vaccinated with Covishield or Covaxin. This is for the 1st time that a booster dose that is different from the one used for primary vaccination has been allowed in India.

WHO?

India's first indigenously developed RBD protein subunit vaccine Corbevax is currently being used to inoculate children in the age group of 12 to 14 years under the COVID-19 immunisation programme.

WHEN?

The COVID-19 Working Group (CWG), in its July 20 meeting, reviewed data of the double-blind randomised phase-3 clinical study which evaluated the immunogenicity and safety of a booster dose of Corbevax vaccine when administered to COVID-19-negative adult volunteers of age 18-80 years previously vaccinated with two doses of either Covishield or Covaxin.

The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precautionary dose for those aged 18 and above.